- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The global Passive Transdermal Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Passive Transdermal Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Passive Transdermal Drug Delivery market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Passive Transdermal Drug Delivery market has been segmented into Microfluidics, Smart Pill Technology (SPT), etc.
Breakdown by Application, Passive Transdermal Drug Delivery has been segmented into Clinic, Hospital, Others, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Passive Transdermal Drug Delivery market presented in the report. This section sheds light on the sales growth of different regional and country-level Passive Transdermal Drug Delivery markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Passive Transdermal Drug Delivery market.
For Japan, this report analyses the Japan market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Passive Transdermal Drug Delivery Market Share Analysis
Passive Transdermal Drug Delivery competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Passive Transdermal Drug Delivery sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Passive Transdermal Drug Delivery sales, revenue and market share for each player covered in this report.
The major players covered in Passive Transdermal Drug Delivery are: 3M, Johnson & Johnson (Janssen Pharmaceuticals Inc.), Boehringer Ingelheim GmbH, Actavis, Inc., GlaxoSmithKline plc, Bayer AG, Novartis AG, Echo Therapeutics, Inc., Corium International, Inc., Mylan N.V., Noven Pharmaceuticals, Inc., Transdermal Corp., etc. Among other players domestic and global, Passive Transdermal Drug Delivery market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Passive Transdermal Drug Delivery market are listed below:
3M
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Boehringer Ingelheim GmbH
Actavis, Inc.
GlaxoSmithKline plc
Bayer AG
Novartis AG
Echo Therapeutics, Inc.
Corium International, Inc.
Mylan N.V.
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
Microfluidics
Smart Pill Technology (SPT)
Market segment by Application, can be divided into
Clinic
Hospital
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Passive Transdermal Drug Delivery Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Passive Transdermal Drug Delivery Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Microfluidics
1.2.3 Smart Pill Technology (SPT)
1.3 Market Analysis by Application
1.3.1 Overview: Global Passive Transdermal Drug Delivery Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
1.4.1 Global Passive Transdermal Drug Delivery Revenue and Forecast (2015-2025)
1.4.2 Global Passive Transdermal Drug Delivery Sales and Forecast (2015-2025)
1.5 Global Passive Transdermal Drug Delivery Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 3M
2.1.1 3M Details
2.1.2 3M Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 3M SWOT Analysis
2.1.4 3M Product and Services
2.1.5 3M Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
2.2.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Details
2.2.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) SWOT Analysis
2.2.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Product and Services
2.2.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Boehringer Ingelheim GmbH
2.3.1 Boehringer Ingelheim GmbH Details
2.3.2 Boehringer Ingelheim GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Boehringer Ingelheim GmbH SWOT Analysis
2.3.4 Boehringer Ingelheim GmbH Product and Services
2.3.5 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Actavis, Inc.
2.4.1 Actavis, Inc. Details
2.4.2 Actavis, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Actavis, Inc. SWOT Analysis
2.4.4 Actavis, Inc. Product and Services
2.4.5 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GlaxoSmithKline plc
2.5.1 GlaxoSmithKline plc Details
2.5.2 GlaxoSmithKline plc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GlaxoSmithKline plc SWOT Analysis
2.5.4 GlaxoSmithKline plc Product and Services
2.5.5 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bayer AG
2.6.1 Bayer AG Details
2.6.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bayer AG SWOT Analysis
2.6.4 Bayer AG Product and Services
2.6.5 Bayer AG Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis AG
2.7.1 Novartis AG Details
2.7.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novartis AG SWOT Analysis
2.7.4 Novartis AG Product and Services
2.7.5 Novartis AG Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Echo Therapeutics, Inc.
2.8.1 Echo Therapeutics, Inc. Details
2.8.2 Echo Therapeutics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Echo Therapeutics, Inc. SWOT Analysis
2.8.4 Echo Therapeutics, Inc. Product and Services
2.8.5 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Corium International, Inc.
2.9.1 Corium International, Inc. Details
2.9.2 Corium International, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Corium International, Inc. SWOT Analysis
2.9.4 Corium International, Inc. Product and Services
2.9.5 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Mylan N.V.
2.10.1 Mylan N.V. Details
2.10.2 Mylan N.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Mylan N.V. SWOT Analysis
2.10.4 Mylan N.V. Product and Services
2.10.5 Mylan N.V. Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Noven Pharmaceuticals, Inc.
2.11.1 Noven Pharmaceuticals, Inc. Details
2.11.2 Noven Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Noven Pharmaceuticals, Inc. SWOT Analysis
2.11.4 Noven Pharmaceuticals, Inc. Product and Services
2.11.5 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Transdermal Corp.
2.12.1 Transdermal Corp. Details
2.12.2 Transdermal Corp. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Transdermal Corp. SWOT Analysis
2.12.4 Transdermal Corp. Product and Services
2.12.5 Transdermal Corp. Passive Transdermal Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Passive Transdermal Drug Delivery Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Passive Transdermal Drug Delivery Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: Japan
3.2.1 Key Players Passive Transdermal Drug Delivery Sales in Japan (2018-2019)
3.2.2 Japan Passive Transdermal Drug Delivery Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Passive Transdermal Drug Delivery Manufacturer Market Share in 2019
3.3.2 Top 6 Passive Transdermal Drug Delivery Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Passive Transdermal Drug Delivery Market Size by Geography (2015-2020)
4.1.1 Global Passive Transdermal Drug Delivery Sales by Geography (2015-2020)
4.1.2 Global Passive Transdermal Drug Delivery Revenue by Regions (2015-2020)
4.2 Global Passive Transdermal Drug Delivery Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Passive Transdermal Drug Delivery Sales and Forecast by Regions (2020-2025)
4.2.2 Global Passive Transdermal Drug Delivery Revenue and Forecast by Regions (2020-2025)
4.3 North America Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
4.4 Europe Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
4.6 South America Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Passive Transdermal Drug Delivery Market Size by Country (2015-2020)
5.1.1 North America Passive Transdermal Drug Delivery Sales and Market Share by Country (2015-2020)
5.1.2 North America Passive Transdermal Drug Delivery Revenue and Market Share by Country (2015-2020)
5.2 North America Passive Transdermal Drug Delivery Market Size and Forecast by Country (2020-2025)
5.2.1 North America Passive Transdermal Drug Delivery Sales and Forecast by Country (2020-2025)
5.2.2 North America Passive Transdermal Drug Delivery Revenue and Forecast by Country (2020-2025)
5.3 United States Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
5.4 Canada Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
5.5 Mexico Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Passive Transdermal Drug Delivery Market Size by Country (2015-2020)
6.1.1 Europe Passive Transdermal Drug Delivery Sales by Country (2015-2020)
6.1.2 Europe Passive Transdermal Drug Delivery Revenue by Country (2015-2020)
6.2 Europe Passive Transdermal Drug Delivery Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Passive Transdermal Drug Delivery Sales and Forecast by Country (2020-2025)
6.2.2 Europe Passive Transdermal Drug Delivery Revenue and Forecast by Country (2020-2025)
6.3 Germany Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
6.4 United Kingdom Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
6.5 France Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
6.6 Russia Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
6.7 Italy Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Passive Transdermal Drug Delivery Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Passive Transdermal Drug Delivery Sales by Region (2015-2020)
7.1.2 Asia-Pacific Passive Transdermal Drug Delivery Revenue by Region (2015-2020)
7.2 Asia-Pacific Passive Transdermal Drug Delivery Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Passive Transdermal Drug Delivery Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Passive Transdermal Drug Delivery Revenue and Forecast by Region (2020-2025)
7.3 China Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
7.4 Japan Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
7.5 Korea Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
7.6 India Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
7.7 Southeast Asia Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
7.8 Australia Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Passive Transdermal Drug Delivery Market Size by Country (2015-2020)
8.1.1 South America Passive Transdermal Drug Delivery Sales by Country (2015-2020)
8.1.2 South America Passive Transdermal Drug Delivery Revenue by Country (2015-2020)
8.2 South America Passive Transdermal Drug Delivery Market Size and Forecast by Country (2020-2025)
8.2.1 South America Passive Transdermal Drug Delivery Sales and Forecast by Country (2020-2025)
8.2.2 South America Passive Transdermal Drug Delivery Revenue and Forecast by Country (2020-2025)
8.3 Brazil Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
8.4 Argentina Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Passive Transdermal Drug Delivery Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Passive Transdermal Drug Delivery Sales by Country (2015-2020)
9.1.2 Middle East & Africa Passive Transdermal Drug Delivery Revenue by Country (2015-2020)
9.2 Middle East & Africa Passive Transdermal Drug Delivery Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Passive Transdermal Drug Delivery Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Passive Transdermal Drug Delivery Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
9.4 Turkey Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
9.5 Egypt Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
9.6 South Africa Passive Transdermal Drug Delivery Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Passive Transdermal Drug Delivery Market Size by Type (2015-2020)
10.1.1 Global Passive Transdermal Drug Delivery Sales by Type (2015-2020)
10.1.2 Global Passive Transdermal Drug Delivery Revenue by Type (2015-2020)
10.1.3 Global Passive Transdermal Drug Delivery Price by Type (2015-2020)
10.2 Global Passive Transdermal Drug Delivery Market Size and Forecast by Type (2020-2025)
10.2.1 Global Passive Transdermal Drug Delivery Sales and Forecast by Type (2020-2025)
10.2.2 Global Passive Transdermal Drug Delivery Revenue and Forecast by Type (2020-2025)
10.2.3 Global Passive Transdermal Drug Delivery Price and Forecast by Type (2020-2025)
10.3 Japan Passive Transdermal Drug Delivery Market Size and Forecast by Type (2015-2025)
10.3.1 Japan Passive Transdermal Drug Delivery Market Size by Type (2015-2020)
10.3.2 Japan Passive Transdermal Drug Delivery Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Passive Transdermal Drug Delivery Market Size by Application (2015-2020)
11.1.1 Global Passive Transdermal Drug Delivery Sales by Application (2015-2020)
11.1.2 Global Passive Transdermal Drug Delivery Revenue by Application (2015-2020)
11.1.3 Global Passive Transdermal Drug Delivery Price by Application (2015-2020)
11.2 Global Passive Transdermal Drug Delivery Market Size and Forecast by Application (2020-2025)
11.2.1 Global Passive Transdermal Drug Delivery Sales and Forecast by Application (2020-2025)
11.2.2 Global Passive Transdermal Drug Delivery Revenue and Forecast by Application (2020-2025)
11.2.3 Global Passive Transdermal Drug Delivery Price and Forecast by Application (2020-2025)
11.3 Japan Passive Transdermal Drug Delivery Market Size and Forecast by Application (2015-2025)
11.3.1 Japan Passive Transdermal Drug Delivery Market Size by Application (2015-2020)
11.3.2 Japan Passive Transdermal Drug Delivery Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Passive Transdermal Drug Delivery Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Passive Transdermal Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Passive Transdermal Drug Delivery Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Passive Transdermal Drug Delivery Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. 3M Basic Information, Manufacturing Base and Competitors
Table 6. 3M Passive Transdermal Drug Delivery Major Business
Table 7. 3M Passive Transdermal Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 8. 3M SWOT Analysis
Table 9. 3M Passive Transdermal Drug Delivery Product and Services
Table 10. 3M Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Basic Information, Manufacturing Base and Competitors
Table 12. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Major Business
Table 13. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 14. Johnson & Johnson (Janssen Pharmaceuticals Inc.) SWOT Analysis
Table 15. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product and Services
Table 16. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 18. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Major Business
Table 19. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 20. Boehringer Ingelheim GmbH SWOT Analysis
Table 21. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product and Services
Table 22. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. Actavis, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Actavis, Inc. Passive Transdermal Drug Delivery Major Business
Table 25. Actavis, Inc. Passive Transdermal Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 26. Actavis, Inc. SWOT Analysis
Table 27. Actavis, Inc. Passive Transdermal Drug Delivery Product and Services
Table 28. Actavis, Inc. Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 30. GlaxoSmithKline plc Passive Transdermal Drug Delivery Major Business
Table 31. GlaxoSmithKline plc Passive Transdermal Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 32. GlaxoSmithKline plc SWOT Analysis
Table 33. GlaxoSmithKline plc Passive Transdermal Drug Delivery Product and Services
Table 34. GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 36. Bayer AG Passive Transdermal Drug Delivery Major Business
Table 37. Bayer AG Passive Transdermal Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 38. Bayer AG SWOT Analysis
Table 39. Bayer AG Passive Transdermal Drug Delivery Product and Services
Table 40. Bayer AG Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 41. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 42. Novartis AG Passive Transdermal Drug Delivery Major Business
Table 43. Novartis AG Passive Transdermal Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 44. Novartis AG SWOT Analysis
Table 45. Novartis AG Passive Transdermal Drug Delivery Product and Services
Table 46. Novartis AG Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 47. Echo Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 48. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Major Business
Table 49. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 50. Echo Therapeutics, Inc. SWOT Analysis
Table 51. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product and Services
Table 52. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 53. Corium International, Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Corium International, Inc. Passive Transdermal Drug Delivery Major Business
Table 55. Corium International, Inc. Passive Transdermal Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 56. Corium International, Inc. SWOT Analysis
Table 57. Corium International, Inc. Passive Transdermal Drug Delivery Product and Services
Table 58. Corium International, Inc. Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 59. Mylan N.V. Basic Information, Manufacturing Base and Competitors
Table 60. Mylan N.V. Passive Transdermal Drug Delivery Major Business
Table 61. Mylan N.V. Passive Transdermal Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 62. Mylan N.V. SWOT Analysis
Table 63. Mylan N.V. Passive Transdermal Drug Delivery Product and Services
Table 64. Mylan N.V. Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 65. Noven Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 66. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Major Business
Table 67. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 68. Noven Pharmaceuticals, Inc. SWOT Analysis
Table 69. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product and Services
Table 70. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 71. Transdermal Corp. Basic Information, Manufacturing Base and Competitors
Table 72. Transdermal Corp. Passive Transdermal Drug Delivery Major Business
Table 73. Transdermal Corp. Passive Transdermal Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 74. Transdermal Corp. SWOT Analysis
Table 75. Transdermal Corp. Passive Transdermal Drug Delivery Product and Services
Table 76. Transdermal Corp. Passive Transdermal Drug Delivery Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 77. Global Passive Transdermal Drug Delivery Sales by Manufacturer (2018-2019) (K Units)
Table 78. Global Passive Transdermal Drug Delivery Revenue by Manufacturer (2018-2019) (USD Million)
Table 79. Key Players Passive Transdermal Drug Delivery Sales in Japan (2018-2019) (K Units)
Table 80. Key Players Passive Transdermal Drug Delivery Sales Market Share in Japan (2018-2019)
Table 81. Key Players Revenue of Passive Transdermal Drug Delivery in Japan (2018-2019) (USD Million)
Table 82. Global Passive Transdermal Drug Delivery Sales by Regions (2015-2020) (K Units)
Table 83. Global Passive Transdermal Drug Delivery Sales Market Share by Regions (2015-2020)
Table 84. Global Passive Transdermal Drug Delivery Revenue by Regions (2015-2020) (USD Million)
Table 85. Global Passive Transdermal Drug Delivery Sales and Forecast by Regions (2020-2025) (K Units)
Table 86. Global Passive Transdermal Drug Delivery Sales Market Share by Regions (2020-2025)
Table 87. Global Passive Transdermal Drug Delivery Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 88. Global Passive Transdermal Drug Delivery Revenue Market Share by Regions (2020-2025) (USD Million)
Table 89. North America Passive Transdermal Drug Delivery Sales by Countries (2015-2020) (K Units)
Table 90. North America Passive Transdermal Drug Delivery Sales Market Share by Countries (2015-2020)
Table 91. North America Passive Transdermal Drug Delivery Revenue by Countries (2015-2020) (USD Million)
Table 92. North America Passive Transdermal Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 93. North America Passive Transdermal Drug Delivery Sales by Country (2020-2025) (K Units)
Table 94. North America Passive Transdermal Drug Delivery Sales Market Share by Country (2020-2025)
Table 95. North America Passive Transdermal Drug Delivery Revenue by Country (2020-2025) (USD Million)
Table 96. North America Passive Transdermal Drug Delivery Revenue Market Share by Country (2020-2025)
Table 97. Europe Passive Transdermal Drug Delivery Sales by Countries (2015-2020) (K Units)
Table 98. Europe Passive Transdermal Drug Delivery Sales Market Share by Countries (2015-2020)
Table 99. Europe Passive Transdermal Drug Delivery Revenue by Countries (2015-2020) (USD Million)
Table 100. Europe Passive Transdermal Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 101. Europe Passive Transdermal Drug Delivery Sales by Country (2020-2025) (K Units)
Table 102. Europe Passive Transdermal Drug Delivery Sales Market Share by Country (2020-2025)
Table 103. Europe Passive Transdermal Drug Delivery Revenue by Country (2020-2025) (USD Million)
Table 104. Europe Passive Transdermal Drug Delivery Revenue Market Share by Country (2020-2025)
Table 105. Asia-Pacific Passive Transdermal Drug Delivery Sales by Countries (2015-2020) (K Units)
Table 106. Asia-Pacific Passive Transdermal Drug Delivery Sales Market Share by Countries (2015-2020)
Table 107. Asia-Pacific Passive Transdermal Drug Delivery Revenue by Countries (2015-2020) (USD Million)
Table 108. Asia-Pacific Passive Transdermal Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 109. Asia-Pacific Passive Transdermal Drug Delivery Sales by Country (2020-2025) (K Units)
Table 110. Asia-Pacific Passive Transdermal Drug Delivery Sales Market Share by Country (2020-2025)
Table 111. Asia-Pacific Passive Transdermal Drug Delivery Revenue by Country (2020-2025) (USD Million)
Table 112. Asia-Pacific Passive Transdermal Drug Delivery Revenue Market Share by Country (2020-2025)
Table 113. South America Passive Transdermal Drug Delivery Sales by Countries (2015-2020) (K Units)
Table 114. South America Passive Transdermal Drug Delivery Sales Market Share by Countries (2015-2020)
Table 115. South America Passive Transdermal Drug Delivery Revenue by Countries (2015-2020) (USD Million)
Table 116. South America Passive Transdermal Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 117. South America Passive Transdermal Drug Delivery Sales by Country (2020-2025) (K Units)
Table 118. South America Passive Transdermal Drug Delivery Sales Market Share by Country (2020-2025)
Table 119. South America Passive Transdermal Drug Delivery Revenue by Country (2020-2025) (USD Million)
Table 120. South America Passive Transdermal Drug Delivery Revenue Market Share by Country (2020-2025)
Table 121. Middle East & Africa Passive Transdermal Drug Delivery Sales by Countries (2015-2020) (K Units)
Table 122. Middle East & Africa Passive Transdermal Drug Delivery Sales Market Share by Countries (2015-2020)
Table 123. Middle East & Africa Passive Transdermal Drug Delivery Revenue by Countries (2015-2020) (USD Million)
Table 124. Middle East & Africa Passive Transdermal Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 125. Middle East & Africa Passive Transdermal Drug Delivery Sales by Country (2020-2025) (K Units)
Table 126. Middle East & Africa Passive Transdermal Drug Delivery Sales Market Share by Country (2020-2025)
Table 127. Middle East & Africa Passive Transdermal Drug Delivery Revenue by Country (2020-2025) (USD Million)
Table 128. Middle East & Africa Passive Transdermal Drug Delivery Revenue Market Share by Country (2020-2025)
Table 129. Japan Passive Transdermal Drug Delivery Sales by Type (2015-2020) (K Units)
Table 130. Japan Passive Transdermal Drug Delivery Sales Market Share by Type (2015-2020)
Table 131. Japan Passive Transdermal Drug Delivery Revenue by Type (2015-2020) (USD Million)
Table 132. Japan Passive Transdermal Drug Delivery Revenue Market Share by Type (2015-2020)
Table 133. Japan Passive Transdermal Drug Delivery Sales by Type (2020-2025) (K Units)
Table 134. Japan Passive Transdermal Drug Delivery Sales Market Share by Type (2020-2025)
Table 135. Japan Passive Transdermal Drug Delivery Revenue by Type (2020-2025) (USD Million)
Table 136. Japan Passive Transdermal Drug Delivery Revenue Market Share by Type (2020-2025)
Table 137. Global Passive Transdermal Drug Delivery Sales by Application (2015-2020) (K Units)
Table 138. Global Passive Transdermal Drug Delivery Sales Market Share by Application (2015-2020)
Table 139. Global Passive Transdermal Drug Delivery Revenue by Application (2015-2020) (USD Million)
Table 140. Global Passive Transdermal Drug Delivery Revenue Market Share by Application (2015-2020)
Table 141. Global Passive Transdermal Drug Delivery Price by Application (2015-2020) (USD/Unit)
Table 142. Global Passive Transdermal Drug Delivery Sales by Application (2020-2025) (K Units)
Table 143. Global Passive Transdermal Drug Delivery Sales Market Share by Application (2020-2025)
Table 144. Global Passive Transdermal Drug Delivery Revenue by Application (2020-2025) (USD Million)
Table 145. Global Passive Transdermal Drug Delivery Revenue Market Share by Application (2020-2025)
Table 146. Global Passive Transdermal Drug Delivery Price by Application (2020-2025) (USD/Unit)
Table 147. Japan Passive Transdermal Drug Delivery Sales by Application (2015-2020) (K Units)
Table 148. Japan Passive Transdermal Drug Delivery Sales Market Share by Application (2015-2020)
Table 149. Japan Passive Transdermal Drug Delivery Revenue by Application (2015-2020) (USD Million)
Table 150. Japan Passive Transdermal Drug Delivery Revenue Market Share by Application (2015-2020)
Table 151. Japan Passive Transdermal Drug Delivery Sales by Application (2020-2025) (K Units)
Table 152. Japan Passive Transdermal Drug Delivery Sales Market Share by Application (2020-2025)
Table 153. Japan Passive Transdermal Drug Delivery Revenue by Application (2020-2025) (USD Million)
Table 154. Japan Passive Transdermal Drug Delivery Revenue Market Share by Application (2020-2025)
Table 155. Direct Channel Pros & Cons
Table 156. Indirect Channel Pros & Cons
Table 157. Distributors/Traders/ Dealers List
Table 158. Customers of Passive Transdermal Drug Delivery
Table 159. Market Opportunities in Next Few Years
Table 160. Market Risks Analysis
Table 161. Market Drivers
List of Figures
Figure 1. Passive Transdermal Drug Delivery Picture
Figure 2. Global Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Microfluidics Picture
Figure 4. Smart Pill Technology (SPT) Picture
Figure 5. Passive Transdermal Drug Delivery Sales Market Share by Application in 2019
Figure 6. Clinic Picture
Figure 7. Hospital Picture
Figure 8. Others Picture
Figure 9. Global Passive Transdermal Drug Delivery Market Status and Outlook (2015-2025) (USD Million)
Figure 10. Global Passive Transdermal Drug Delivery Sales Growth Rate (2015-2025) (K Units)
Figure 11. Global Passive Transdermal Drug Delivery Sales Market Share by Manufacturer in 2019
Figure 12. Global Passive Transdermal Drug Delivery Revenue Market Share by Manufacturer in 2019
Figure 13. Key Players Passive Transdermal Drug Delivery Revenue Market Share in Japan in 2019
Figure 14. Global Top 5 Passive Transdermal Drug Delivery Manufacturer Market Share in 2019
Figure 15. Top 3 Passive Transdermal Drug Delivery Players Market Share in Japan in 2019
Figure 16. Global Passive Transdermal Drug Delivery Revenue Market Share by Regions in 2019
Figure 17. North America Passive Transdermal Drug Delivery Sales YoY Growth (2015-2025) (K Units)
Figure 18. North America Passive Transdermal Drug Delivery Revenue YoY Growth (2015-2025) (USD Million)
Figure 19. Europe Passive Transdermal Drug Delivery Sales YoY Growth (2015-2020) (K Units)
Figure 20. Europe Passive Transdermal Drug Delivery Revenue YoY Growth (2015-2020) (USD Million)
Figure 21. Asia-Pacific Passive Transdermal Drug Delivery Sales YoY Growth (2015-2020) (K Units)
Figure 22. Asia-Pacific Passive Transdermal Drug Delivery Revenue YoY Growth (2015-2020) (USD Million)
Figure 23. South America Passive Transdermal Drug Delivery Sales YoY Growth (2015-2020) (K Units)
Figure 24. South America Passive Transdermal Drug Delivery Revenue YoY Growth (2015-2020) (USD Million)
Figure 25. Middle East & Africa Passive Transdermal Drug Delivery Sales YoY Growth (2015-2020) (K Units)
Figure 26. Middle East & Africa Passive Transdermal Drug Delivery Revenue YoY Growth (2015-2020) (USD Million)
Figure 27. North America Passive Transdermal Drug Delivery Sales Market Share by Country in 2019
Figure 28. North America Passive Transdermal Drug Delivery Revenue Market Share by Country in 2019
Figure 29. United States Passive Transdermal Drug Delivery Market Size and Growth Rate (2015-2025) (USD Million)
Figure 30. Canada Passive Transdermal Drug Delivery Market Size and Growth Rate (2015-2025) (USD Million)
Figure 31. Mexico Passive Transdermal Drug Delivery Market Size and Growth Rate (2015-2020) (USD Million)
Figure 32. Europe Passive Transdermal Drug Delivery Revenue Market Share by Country in 2019
Figure 33. Germany Passive Transdermal Drug Delivery Market Size Growth Rate (2015-2025) (USD Million)
Figure 34. United Kingdom Passive Transdermal Drug Delivery Market Size Growth Rate (2015-2025) (USD Million)
Figure 35. France Passive Transdermal Drug Delivery Market Size Growth Rate (2015-2025) (USD Million)
Figure 36. Russia Passive Transdermal Drug Delivery Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. Italy Passive Transdermal Drug Delivery Market Size Growth Rate (2015-2025) (USD Million)
Figure 38. Asia-Pacific Passive Transdermal Drug Delivery Sales Market Share by Region 2018
Figure 39. Asia-Pacific Passive Transdermal Drug Delivery Revenue Market Share by Region 2018
Figure 40. China Passive Transdermal Drug Delivery Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. Japan Passive Transdermal Drug Delivery Market Size Growth Rate (2015-2025) (USD Million)
Figure 42. Korea Passive Transdermal Drug Delivery Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. India Passive Transdermal Drug Delivery Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Southeast Asia Passive Transdermal Drug Delivery Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. Australia Passive Transdermal Drug Delivery Market Size Growth Rate (2015-2025) (USD Million)
Figure 46. South America Passive Transdermal Drug Delivery Sales Market Share by Country in 2019
Figure 47. South America Passive Transdermal Drug Delivery Revenue Market Share by Country in 2019
Figure 48. Brazil Passive Transdermal Drug Delivery Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. Argentina Passive Transdermal Drug Delivery Market Size Growth Rate (2015-2025) (USD Million)
Figure 50. Saudi Arabia Passive Transdermal Drug Delivery Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Turkey Passive Transdermal Drug Delivery Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. Egypt Passive Transdermal Drug Delivery Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. South Africa Passive Transdermal Drug Delivery Market Size Growth Rate (2015-2025) (USD Million)
Figure 54. Global Revenue Market Share of Passive Transdermal Drug Delivery by Type in 2019
Figure 55. Global Revenue Market Share of Passive Transdermal Drug Delivery by Application in 2019
Figure 56. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
